Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by scarlet1967

T.TH

The link between NAFLD and Metabolic Syndrome

In the latest PR they said based on their recent post- hoc analysis from...

February 26, 2023

T.TH

RE:RE:AASLD guidance 2023

February 3!   https://journals.lww.com/hep/citation/9900/aasld...

February 22, 2023

T.TH

Long acting injectable

"Turning to emerging technologies, Dr Fauci envisions the renaissance of...

February 22, 2023

T.TH

AASLD guidance 2023

  "Associated endocrine disorders In addition to its strong...

February 22, 2023

T.TH

RE:RE:RE:Presentation post or link?

"11:00 am Case Study: A First-In-Class Peptide Drug Conjugate (PDC...

February 22, 2023

T.TH

RE:NASH is Back

Well they now have posted on the LinkedIn... https://www.linkedin.com/posts...

February 20, 2023

T.TH

RE:RE:From Linkedin

ViiV Healthcare at CROI 2023 ViiV Healthcare at CROI 2023 https://www...

February 20, 2023

T.TH

THTX's NASH asset

The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver...

February 18, 2023

T.TH

29 percent institutional ownership

"We are pleased that under WODA’s Named Patient Program adults living...

February 18, 2023

T.TH

THTX read this

https://ca.finance.yahoo.com/news/retail-investors-record-inflows-us-stock...

February 16, 2023

T.TH

RE:RE:Tesamorelin phase 4 trial!

Marcel49 wrote: Who initiate this study and who pay for it? Sponsors and...

February 16, 2023

T.TH

RE:RE:RE:RE:RE:New Press Release - Theratechnologies Announces Path to Resume TH1902 Clinical Development

On the previous corporate presentation they did say their intention were to...

February 16, 2023

T.TH

Tesamorelin phase 4 trial!

  I didn't know there was an ongoing trial by Columbia...

February 15, 2023

T.TH

Corporate presentation.,,

It has been taken down despite the fact it was last updated 5 weeks ago! I...

February 15, 2023

T.TH

Posted on LinkedIn

https://www.linkedin.com/posts/mashman45_thera-speaker-interview-activity...

February 14, 2023

T.TH

RE:Odds

Well they have been showing of their oncology scientists lately and now the...

February 13, 2023

T.TH

What to use next?

The Basics of Switching HIV Treatment The Basics of Switching HIV Treatment...

February 13, 2023

T.TH

Posted by THTX

https://www.linkedin.com/posts/theratechnologies-inc...

February 11, 2023

T.TH

RE:Alogos news

While this company is reducing workforce THTX is still recruiting. This one...

February 8, 2023

T.TH

Posted by THTX

https://www.linkedin.com/posts/theratechnologies-inc_worldcancerday-cancer...

February 4, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NexTech3D.AI Corp.

NexTech3D.AI Corp. C.NTAR

NexTech3D.AI Corp. is a diversified augmented reality (AR), artificial intelligence (AI) technology company. The Company ... view more »